BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,752 | -99.6% | 2,669 | -98.9% | 0.00% | -100.0% |
| Q2 2023 | $1,611,440 | -4.8% | 241,958 | +199.1% | 0.01% | -28.6% |
| Q1 2022 | $1,692,000 | -54.6% | 80,900 | -68.3% | 0.01% | -65.0% |
| Q4 2019 | $3,726,000 | +152.1% | 255,000 | +21.4% | 0.02% | +122.2% |
| Q3 2019 | $1,478,000 | +912.3% | 210,000 | +1001.7% | 0.01% | +800.0% |
| Q3 2018 | $146,000 | -75.9% | 19,062 | -71.0% | 0.00% | -50.0% |
| Q2 2018 | $605,000 | -0.7% | 65,809 | +10.7% | 0.00% | -33.3% |
| Q1 2018 | $609,000 | – | 59,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |